Rice Hall James & Associates’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.8M | Sell |
231,993
-2,703
| -1% | -$138K | 0.64% | 46 |
|
|
2025
Q1 | $10.6M | Sell |
234,696
-4,303
| -2% | -$194K | 0.62% | 47 |
|
|
2024
Q4 | $9.88M | Sell |
238,999
-3,712
| -2% | -$153K | 0.54% | 54 |
|
|
2024
Q3 | $9.47M | Buy |
242,711
+12,981
| +6% | +$506K | 0.51% | 54 |
|
|
2024
Q2 | $7.85M | Buy |
229,730
+14,843
| +7% | +$507K | 0.47% | 58 |
|
|
2024
Q1 | $5.4M | Buy |
214,887
+172,047
| +402% | +$4.32M | 0.31% | 71 |
|
|
2023
Q4 | $1.26M | Sell |
42,840
-10,539
| -20% | -$311K | 0.07% | 207 |
|
|
2023
Q3 | $1.69M | Sell |
53,379
-1,075
| -2% | -$34K | 0.11% | 182 |
|
|
2023
Q2 | $1.41M | Buy |
54,454
+2,159
| +4% | +$55.9K | 0.08% | 196 |
|
|
2023
Q1 | $1.26M | Buy |
+52,295
| New | +$1.26M | 0.07% | 229 |
|